<DOC>
	<DOCNO>NCT01118572</DOCNO>
	<brief_summary>Aim study compare efficacy safety YM177 placebo etodolac patient postoperative pain .</brief_summary>
	<brief_title>A Study Verify Efficacy YM177 ( Celecoxib ) Postoperative Pain Patients</brief_title>
	<detailed_description>To verify superiority placebo noninferiority etodolac YM177 term efficacy assessment patient postoperative pain . Also , compare term safety assessment .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Etodolac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients spontaneous pain within 24 hour postoperatively The intensity pain : 4categorical assessment : `` Moderate pain '' `` Severe pain '' VAS assessment : 45.0 mm high Patients whose postoperative pain manage use oral NSAID A past history aspirininduced asthma A past ischemic heart disease , serious arrhythmia , congestive heart failure cerebrovascular disease Patients undergoes surgical procedure general anesthesia Patients take excluded medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Celecoxib</keyword>
	<keyword>Celecox</keyword>
	<keyword>Pain</keyword>
	<keyword>Surgery</keyword>
	<keyword>NSAIDs</keyword>
</DOC>